Instrument and reagent vendors at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

109 instrument and reagent vendors are at AMP 2026 — 66 presentations on the program and 104 with a booth in the exhibit hall. Most represented: PacBio (3 on the program), Promega (3 on the program), Bio-Rad Laboratories (2 on the program). 37 of them have their own page in this guide. As of Sep 25, 2026.

All 298 organizations at AMP 2026 →

Showing 1–10 of 109 organizations

Organization	AMP 2026 Attendance
PacBio Menlo Park, CA
pacb.com Suppliers Sequencing technologies combining long reads with high accuracy for genomes, transcriptomes and epigenomes.	Booth Exhibiting at Booth 1018 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 9:00am–9:50am Full Stack Somatic: Connecting Long-Read HiFi WGS to Clinical Genomic Reporting A containerized somatic long-read whole-genome pipeline running from raw data through variant interpretation to a clinical report. Workshop hosted by GenomOncology Chelan 2, Level 2, Arch at 800 Pike Workshop Fri, Nov 13 12:00pm–12:30pm Accelerating Clinical Genomics with HiFi Sequencing: Targeted and Rapid Whole-Genome Workflows Long-read workflows for repeat expansion disorders and other hard genomic regions, plus a faster whole-genome protocol. Innovation Spotlight Stage #2
Promega Madison, WI
promega.com Suppliers Nucleic acid extraction, PCR reagents and custom or OEM manufacturing for clinical laboratories, with technical support.	Booth Exhibiting at Booth 610 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am From Hands-On to Hands-Off: Automating FFPE, Blood, and Bone Marrow Extraction on the Clear Dx System Automated nucleic acid extraction from FFPE, blood and bone marrow, with yield reproducibility, contamination checks and time saved. Chelan 4, Level 2, Arch at 800 Pike Workshop Wed, Nov 11 9:00am–9:50am OncoMate® MSI Dx as a Companion Diagnostic for Microsatellite Instability: Clinical Context, Validation, and Performance Microsatellite instability testing as a companion diagnostic for checkpoint inhibitor eligibility, with accuracy and concordance data. Chelan 4, Level 2, Arch at 800 Pike
Bio-Rad Laboratories Hercules, CA
bio-rad.com Suppliers Products for life science research and clinical diagnostics, including droplet digital PCR, real-time PCR and molecular quality controls and standards.	Booth Exhibiting at Booth 537, MR16 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am MRD Detection & Monitoring in Solid Tumors and Heme Malignancies Using Personalized Tumor Informed Droplet Digital PCR (ddPCR) Assays in Research Settings Tumour-informed droplet digital PCR assays for tracking residual disease in both blood cancers and solid tumours. Tahoma 3, Level 3, Arch at 800 Pike Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking More from Every Sample: New Multiplex Oncology Assays and Emerging MRD Applications with the QX700™ ddPCR™ System Multiplexed droplet digital PCR assays that pull more oncology biomarker data from limited samples, including residual disease monitoring. Innovation Spotlight Stage #2
Cellecta Mountain View, CA
cellecta.com Suppliers Genomic products and services for drug target and biomarker discovery: viral vector production, functional screening, cell engineering and multiplex qRT-PCR.	Booth Exhibiting at Booth 2205 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm From Repertoire to Response: A Workflow for Mapping Antigen-Specific T- and B-Cell Clonotypes for Receptor-Based Target Discovery Pairing immune receptor sequencing with antigen screening to rank tumour-specific T- and B-cell clonotypes, including from plasma. Tahoma 5, Level 3, Arch at 800 Pike Workshop Sat, Nov 14 9:30am–10:00am Discovery and Validation of T- and B-Cell Clonotypes to Drive Next-Level Drug and Biomarker Discovery An end-to-end route from bulk and single-cell receptor sequencing to screening that surfaces drug and biomarker candidates. Innovation Spotlight Stage #1
Countable Labs Palo Alto, CA
countablelabs.com Suppliers Countable PCR uses single-molecule isolation for fusion and rare variant detection, minimal residual disease monitoring and absolute ctDNA quantification.	Booth Exhibiting at Booth 943 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. Tahoma 2, Level 3, Arch at 800 Pike
Covaris Woburn, MA
covaris.com Suppliers Sample preparation for multiomics research and clinical labs, using focused-acoustics instruments, consumables, reagents and kits. A PerkinElmer company.	Booth Exhibiting at Booth 2409 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 3:00pm–3:50pm Optimizing FFPE tissue stewardship: Covaris truXTRAC automated workflow delivers superior performance for tumor-informed Haystack® MRD assay Getting more DNA and RNA from each FFPE slide so scarce tumour tissue stretches across several sequencing assays. Yakima 2, Level 1, Arch at 800 Pike Workshop Thu, Nov 12 3:45pm–4:15pm Optimized Automated Extraction for FFPE Tissue Cores Automated simultaneous DNA and RNA extraction from FFPE cores and sections, validated for sequencing-grade yield. Innovation Spotlight Stage #1
Illumina San Diego, CA
illumina.com SuppliersGold Partner Sequencing instruments and reagents for clinical, research and applied markets, spanning oncology, reproductive health and genetic disease.	Booth Exhibiting at Booth 727, MR1, MR2 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Gold Partner Workshop Wed, Nov 11 11:00am–11:50am Expanding Precision Oncology: Practical Strategies for Integrating Tissue and Liquid Biopsy Comprehensive Genomic Profiling Tissue and liquid biopsy genomic profiling run side by side, covering test algorithms, lab operations and case examples. Skagit 5, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 12:00pm–12:50pm Genome as a Platform: Advancing MRD Research with Illumina Whole Genome Sequencing Oncology Prep Whole-genome sequencing as a single platform for molecular residual disease research, with early analytical performance data. Skagit 5, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 2:00pm–2:50pm Unlocking AML Biology with 5-Base Whole-Genome Sequencing: Integrated Genomic and Epigenomic Profiling for Biomarker Discovery Five-base whole-genome sequencing reads methylation and genomic variation from one AML sample to find research biomarkers. Skagit 1, Lower Level, Arch at 800 Pike Workshop Fri, Nov 13 3:00pm–3:30pm Comprehensive Tumor Profiling Beyond Panels: Methylation-Aware WGS Enabled by Advanced Informatics Whole-genome sequencing with methylation and fragmentomic analysis moves tumor profiling beyond targeted panels, using DRAGEN informatics. Innovation Spotlight Stage #1
Thermo Fisher Scientific Waltham, MA
thermofisher.com SuppliersSilver Partner Research and diagnostic solutions for molecular laboratories: next-generation sequencing, real-time PCR, Sanger sequencing and bioinformatics across oncology, pharmacogenomics and infectious disease.	Booth Exhibiting at Booth 709, MR10, MR4 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Silver Partner Workshop Wed, Nov 11 10:00am–10:50am Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable. Skagit 2, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 11:00am–11:50am Novel NGS Applications in Oncology Research: TCR Sequencing and Methylation-Based ctDNA Analysis T-cell receptor sequencing and methylation-based circulating tumor DNA analysis open new angles on immune response and tumor signals. Skagit 2, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 1:00pm–1:50pm Implementing Clinical Pharmacogenomics: Practical Lessons from Assay to Actionable Care Getting pharmacogenomic testing into routine care: test selection, lab workflow, reporting, reimbursement and health record integration. Skagit 2, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 2:00pm–2:50pm Advancing precision oncology research: Integrating pharmacogenomics and genomic profiling using a single, rapid NGS workflow on the Genexus System Folding DPYD pharmacogenomic content into tumour sequencing so one run covers both drug-response and tumour profiling. Skagit 2, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 3:00pm–3:50pm Bridging the Clinical Gap: Retrospective Microsatellite Instability Testing to Inform Complex Biospecimen Cohort Generation Microsatellite instability testing across hundreds of banked tumor specimens builds characterized cohorts for immunotherapy research. Skagit 2, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. Skagit 2, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 9:00am–9:50am From Assay to Answer: Genomic Technologies and Multiplex Workflow Solutions for Infectious Disease Research Pathogen detection by qPCR and digital PCR, with assay design and multiplexing choices for adding targets within one reaction. Skagit 2, Lower Level, Arch at 800 Pike Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. Innovation Spotlight Stage #1 Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking New Possibilities in Myeloid Malignancies MRD Assessment with NGS An NGS assay for measurable residual disease in myeloid cancers, covering its gene content, workflow and reported performance. Innovation Spotlight Stage #1
LGC Teddington, UK
lgcgroup.com Suppliers Quality controls, reference materials, diagnostic panels, NGS controls and proficiency testing for clinical laboratories, through its SeraCare clinical diagnostics business.	Booth Exhibiting at Booth 1804, MR13 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm You’re So Naïve: Best Practices and Gold-Standard Reference Material for Tumor-Agnostic MRD Testing Tumor-agnostic residual disease assays face validation hurdles, weighed against tumor-informed testing alongside reference materials. Tahoma 3, Level 3, Arch at 800 Pike
QIAGEN Venlo, Netherlands
qiagen.com Suppliers Sample preparation kits, assay technologies and bioinformatics for extracting DNA and RNA insights in research, clinical and applied testing laboratories.	Booth Exhibiting at Booth 529, MR18 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 1:00pm–1:50pm Advancing Cell-Free Nucleic Acid Testing: Integrated Workflows for Prenatal and Oncology Applications Cell-free DNA and RNA workflows for prenatal screening and oncology, including why DNA-only sequencing misses actionable fusions. Chelan 5, Level 2, Arch at 800 Pike Workshop Wed, Nov 11 2:00pm–2:50pm Building Scalable Clinical Genomics Workflows: Practical Lessons from Leading Laboratories Scaling sequencing operations in molecular labs, plus how to keep trust in AI-assisted variant interpretation. Chelan 5, Level 2, Arch at 800 Pike